HCW Biologics
HCWB • NASDAQ
HCW Biologics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Hing C. Wong, with a market cap of $1.4M.
CEOHing C. Wong
Next Earnings
Upcoming earnings announcement for HCW Biologics
Date
Thursday, May 14, 2026 (in a month)
Timing
After Market Close (6:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.44
Earnings History
Past 12 earnings reports for HCW Biologics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Q4 2025 | -$1.02Est: -$0.84 | -21.4% | $27.0KEst: $7.0M | -99.6% |  10-K |
| Nov 14, 2025 | Q3 2025 | -$2.02Est: $1.58 | -227.8% | $15.6MEst: $7.0M | +122.9% | 10-Q |
| Aug 18, 2025 | Q2 2025 | -$6.79Est: -$2.30 | -195.2% | $6.6KEst: $7.0M | -99.9% | 10-Q |
| May 15, 2025 | Q1 2025 | -$0.05 | — | $5.1K | — | 10-Q |
| Mar 28, 2025 | Q4 2024 | -$0.08 | — | $394.8K | — | 10-K |
| Nov 14, 2024 | Q3 2024 | -$0.10 | — | $426.4K | — | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$0.40 | — | $618.9K | — | 10-Q |
| May 15, 2024 | Q1 2024 | -$0.20 | — | $1.1M | — | 10-Q |
| Apr 1, 2024 | Q4 2023 | -$0.30Est: -$0.14 | -114.3% | $560.4KEst: $900.0K | -37.7% | 10-K/A |
| Nov 14, 2023 | Q3 2023 | -$0.14Est: -$0.13 | -7.7% | $853.1KEst: $300.0K | +184.4% | — |
| Aug 11, 2023 | Q2 2023 | -$0.12Est: -$0.15 | +20.0% | $622.8K | — | 10-Q |
| May 9, 2023 | Q1 2023 | -$0.14Est: -$0.14 | 0.0% | $41.9KEst: $1.2M | -96.4% | — |